News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Travere Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Policy
Ex-Retrophin CEO Sold Stock While Urging Investors To Buy
November 26, 2014
·
2 min read
Business
Retrophin Booted CEO For Multiple Stock Violations: Report
October 3, 2014
·
2 min read
Biotech Bay
Retrophin, Inc., Gilead Sciences, Inc., And Our Healthcare Values
September 15, 2014
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS
January 14, 2026
·
16 min read
Press Releases
Travere Therapeutics Provides Corporate Update and 2026 Outlook
January 13, 2026
·
17 min read
Press Releases
Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 11, 2025
December 12, 2025
·
1 min read
Press Releases
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 10, 2025
November 10, 2025
·
1 min read
Press Releases
Travere Therapeutics Announces Late-Breaking Data from Phase 3 DUPLEX Study of FILSPARI in FSGS Presented at the American Society of Nephrology (ASN) Kidney Week 2025
November 7, 2025
·
18 min read
Press Releases
Travere Therapeutics to Participate at Upcoming Investor Conferences - November 4, 2025
November 4, 2025
·
1 min read
Press Releases
Travere Therapeutics Reports Third Quarter 2025 Financial Results
October 31, 2025
·
19 min read
Press Releases
Travere Therapeutics to Report Third Quarter 2025 Financial Results
October 23, 2025
·
1 min read
Press Releases
Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2025
October 20, 2025
·
19 min read
